ABCDEFGHIJKLMNOPQRSTUVWXYZAA
1
Phase III 4-year follow-up results for severe malaria
2
C3C group (control)
R3C group (3 dose)
R3R group (4 dose)
Point estimate of VE unadjusted for covariates R3C vs C3CPoint estimate of VE unadjusted for covariates R3R vs C3C
3
N (sample size)n (# cases)
Proportion affected*
Nn
Proportion affected*
Nn
Proportion affected*
VE (95% CI)p valueVE (95% CI)p value
4
5–17 months age category
5
Month 0 to study end29741710.0629721690.0629761160.041·1% (−23·0 to 20·5)0·9632·2% (13·7 to 46·9)0·0009
6
Months 0–3229741520.0529721450.052976990.034·5% (−20·6 to 24·5)0·7234·9% (15·6 to 50·0)0·0006
7
Months 0–20†29741180.0459491560.0359491560.0333·9% (15·3 to 48·3)0·0007....
8
Months 21–322701420.022717610.022679430.02−44·4% (−119·0 to 4·1)0·073−3·2% (−61·8 to 34·1)0·91
9
Month 33 to study end2309200.012267310.012236230.01−57·9% (−192·0 to 12·8)0·12−18·8% (−128·0 to 37·6)0·65
10
Month 21 to study end2702620.022719880.032681640.02−41·0% (−98·5 to −0·8)0·038−4·0% (−50·0 to 27·8)0·86
11
GiveWell calculations
12
Minimum cases from Month 0-2029741090.0372972810.0272976520.01725.64%52.33%
13
14
Control group
Average of treatment groups
Combined VE
15
Average of R3C and R3R, month 0-2029741090.037297466.50.022439.0%
16
17
VE against severe malaria, 3 dose groupVE against severe malaria, 4 dose group
Subjective Weight
VE against severe malaria, (0-20 months) 3 dose groupVE against severe malaria (0-20 months), 4 dose group
Subjective Weight
18
4 dose group "got lucky", its results from months 0-20 should look like 3 dose group 1.1%15.3%40%25.6%25.6%40%
19
3 dose group "got unlucky", its results from months 0-20 should look like 4 dose group27.1%32.2%60%52.3%52.3%60%
20
Weighted estimate of VE against severe malaria16.7%25.4%42%42%
21
22
Check: Does this recreate the VE of the published results? 1.10%32.2%
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100